S. Hopkins

678 total citations
11 papers, 508 citations indexed

About

S. Hopkins is a scholar working on Epidemiology, Pharmacology and Surgery. According to data from OpenAlex, S. Hopkins has authored 11 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Pharmacology and 3 papers in Surgery. Recurrent topics in S. Hopkins's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Pneumonia and Respiratory Infections (4 papers) and Urinary Tract Infections Management (2 papers). S. Hopkins is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Pneumonia and Respiratory Infections (4 papers) and Urinary Tract Infections Management (2 papers). S. Hopkins collaborates with scholars based in United States and Canada. S. Hopkins's co-authors include Robert B. Jones, Raymond B. Johnson, David H. Martin, Tomasz Mroczkowski, James McCarty, D. Williams, Paul Wheatley‐Price, George Dranitsaris, Nathaniel Bouganim and Lisa Vandermeer and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The American Journal of Medicine.

In The Last Decade

S. Hopkins

10 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Hopkins United States	9	246	203	91	86	83	11	508
W R Bowie Canada	14	252 1.0×	261 1.3×	56 0.6×	80 0.9×	142 1.7×	23	576
Udo B. Hoyme Germany	13	387 1.6×	210 1.0×	82 0.9×	107 1.2×	60 0.7×	59	622
Marilyn Ohm-Smith United States	13	342 1.4×	349 1.7×	141 1.5×	79 0.9×	58 0.7×	22	639
James K. Todd United States	9	299 1.2×	134 0.7×	121 1.3×	69 0.8×	32 0.4×	10	553
Staffan Seeberg Sweden	15	199 0.8×	111 0.5×	57 0.6×	138 1.6×	46 0.6×	37	522
Višnja Škerk Croatia	11	226 0.9×	132 0.7×	31 0.3×	60 0.7×	30 0.4×	38	415
S Schönwald Croatia	12	337 1.4×	131 0.6×	29 0.3×	40 0.5×	74 0.9×	25	507
Lisa Steele United States	15	301 1.2×	45 0.2×	135 1.5×	49 0.6×	29 0.3×	41	666
J. Rüggeberg United Kingdom	9	493 2.0×	191 0.9×	40 0.4×	54 0.6×	115 1.4×	13	734
J. Dankert Netherlands	15	197 0.8×	114 0.6×	30 0.3×	451 5.2×	53 0.6×	31	890

Countries citing papers authored by S. Hopkins

Since Specialization

Citations

This map shows the geographic impact of S. Hopkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hopkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hopkins more than expected).

Fields of papers citing papers by S. Hopkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Hopkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hopkins. The network helps show where S. Hopkins may publish in the future.

Co-authorship network of co-authors of S. Hopkins

This figure shows the co-authorship network connecting the top 25 collaborators of S. Hopkins. A scholar is included among the top collaborators of S. Hopkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Hopkins. S. Hopkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Bouganim, Nathaniel, George Dranitsaris, S. Hopkins, et al.. (2012). Prospective Validation of Risk Prediction Indexes for Acute and Delayed Chemotherapy-Induced Nausea and Vomiting. Current Oncology. 19(6). 414–421. 39 indexed citations

Bouganim, Nathaniel, George Dranitsaris, Lisa Vandermeer, et al.. (2011). Prospective validation of risk prediction models for acute and delayed chemotherapy-induced nausea and vomiting (CINV).. Journal of Clinical Oncology. 29(15_suppl). 6103–6103. 1 indexed citations

Williams, D. & S. Hopkins. (1998). Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin. The American Journal of Surgery. 176(6). 74S–79S. 14 indexed citations

Williams, D. & S. Hopkins. (1998). Safety of trovafloxacin in treatment of lower respiratory tract infections. European Journal of Clinical Microbiology & Infectious Diseases. 17(6). 454–458. 9 indexed citations

Hopkins, S. & D. Williams. (1995). Clinical tolerability and safety of azithromycin in children. The Pediatric Infectious Disease Journal. 14(4). S67–S67. 10 indexed citations

Hopkins, S. & D. Williams. (1995). Five-day azithromycin in the treatment of patients with community-acquired pneumonia. Current Therapeutic Research. 56(9). 915–925. 10 indexed citations

Hopkins, S.. (1993). Clinical safety and tolerance of azithromycin in children. Journal of Antimicrobial Chemotherapy. 31(suppl E). 111–117. 26 indexed citations

Martin, David H., Tomasz Mroczkowski, James McCarty, et al.. (1993). A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis. Obstetrical & Gynecological Survey. 48(2). 123–124. 23 indexed citations

Martin, David H., Tomasz Mroczkowski, James McCarty, et al.. (1992). A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis. New England Journal of Medicine. 327(13). 921–925. 203 indexed citations

10.

Hopkins, S.. (1991). Clinical toleration and safety of azithromycin. The American Journal of Medicine. 91(3). S40–S45. 172 indexed citations

11.

Hopkins, S.. (1987). Prophylactic treatment for venous ulcers.. PubMed. 83(26). 45–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact